ArticleBritish journal of cancer2026

A prospective national precision medicine trial evaluating the feasibility of blood-based molecular profiling in patients with Cancer of Unknown Primary (CUP-COMP).

Alicia-Marie Conway et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.